2016
DOI: 10.1016/j.carbpol.2016.02.030
|View full text |Cite
|
Sign up to set email alerts
|

Structural characterization, α-glucosidase inhibitory and DPPH scavenging activities of polysaccharides from guava

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

2
48
0
2

Year Published

2017
2017
2022
2022

Publication Types

Select...
7

Relationship

1
6

Authors

Journals

citations
Cited by 130 publications
(53 citation statements)
references
References 47 publications
2
48
0
2
Order By: Relevance
“…Reaction kinetics of scavenging capacity against DPPH free radical of EEO DPPH radicals exhibit a purple color in ethanol solution, and their color decreases when they react with antioxidants. Different antioxidants have different rates of scavenging DPPH·free radical (Claudia et al, 2016;Zhang et al, 2016). The results of the reductive capabilities of EEO at different concentrations are presented in Figure 7.…”
Section: Antioxidant Activitymentioning
confidence: 99%
“…Reaction kinetics of scavenging capacity against DPPH free radical of EEO DPPH radicals exhibit a purple color in ethanol solution, and their color decreases when they react with antioxidants. Different antioxidants have different rates of scavenging DPPH·free radical (Claudia et al, 2016;Zhang et al, 2016). The results of the reductive capabilities of EEO at different concentrations are presented in Figure 7.…”
Section: Antioxidant Activitymentioning
confidence: 99%
“…Moreover, Deguchi and Miyazaki [58] suggested that the component that inhibited the in vitro activities of α-glucosidase enzymes in guava extract was a polymerized polyphenol. In addition, polysaccharides from guava leaves also exhibited α-glucosidase inhibition [59]. …”
Section: Pharmacological Propertiesmentioning
confidence: 99%
“…In 2016, a novel polysaccharide GP90‐1B (Figure ), with a nona‐decasaccharide repeating unit, was isolated from the fruit of Psidium guajava , which is a well‐known medicinal plant for the treatment of various ailments such as diabetes, diarrhea, ulcers, and rheumatism . The unique structural features of the glycans of GP90‐1B include the following: 1) a challenging 2,3,5‐branched l ‐arabinofuranose (Ara f ) motif at the reducing end; 2) two 1,2‐ cis ‐glucosidic linkages, which are challenging to construct in a highly stereoselective manner; 3) a long arabinofuranose chain with a 13 α‐(1→5)‐linked Ara f motif at the nonreducing end.…”
Section: Introductionmentioning
confidence: 99%